Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Amplia Therapeutics (ATX)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
EBR Systems (EBR)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
February 18th, 2025
Leading the Way – Adalta's East to West Roadmap
Read More
November 20th, 2023
Adalta Finalises Data for Licensing with Lead Compound AD214
Read More
December 19th, 2022
Adalta Returns to IV Formulation for AD-214
Read More
July 27th, 2021
Adalta Moves to Inhaled Delivery for AD-214
Read More
June 15th, 2021
Adalta Progresses GE Collaboration and Sets Clear Milestones for Path Ahead
Read More
March 15th, 2021
Adalta Phase Ia Results – Multiple Positive Findings
Read More
February 15th, 2021
Adalta’s Prospects Improve
Read More
Pages
1
